8 active warrant series; nearest expiry 2026-10-22.
Compare this book against every issuer →8 option grants covering 26,600,000 shares (~10.3% potential dilution). Counted apart from the warrants above.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| option | $0.80 | Oct 22, 2026 27d | 400K | OTM | 0.2% | C$320K | Auto |
| option | $0.39 | Nov 8, 2027 409d | 2.5M | OTM | 1.0% | C$975K | Auto |
| option | $0.35 | May 25, 2028 608d | 600K | OTM | 0.2% | C$210K | Auto |
| option | $0.48 | Jun 12, 2028 626d | 4.7M | OTM | 1.8% | C$2.3M | Auto |
| option | $0.19 | Feb 7, 2029 866d | 12.0M | OTM | 4.6% | C$2.3M | Auto |
| option | $0.16 | Apr 12, 2029 930d | 3.0M | OTM | 1.2% | C$480K | Auto |
| option | $0.14 | Sep 26, 2030 1462d | 400K | OTM | 0.2% | C$56K | Auto |
| option | $0.13 | Jan 8, 2031 1566d | 3.0M | OTM | 1.2% | C$390K | Auto |
An issuer that discloses only a plan total appears as one line at its weighted-average exercise price and weighted-average remaining life — the filing's own summary, not a per-grant schedule.
258,994,127 shares outstanding, plus 0 from warrants and 26,600,000 from options — a fully diluted 285,594,127 shares, or ~10.3% above today's count if every one of them is exercised.
Price history with the company's supply walls overlaid — warrants (amber), employee and consultant options (pink), and free-trading unlock dates (violet). Each wall sits at the price the paper is struck at today, restated through any consolidation, and is measured in the SHARES it can issue rather than the number of certificates. Levels and dates are Pacific Time.
8 active warrant series; nearest expiry 2026-10-22.
Compare this book against every issuer →8 option grants covering 26,600,000 shares (~10.3% potential dilution). Counted apart from the warrants above.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| option | $0.80 | Oct 22, 2026 27d | 400K | OTM | 0.2% | C$320K | Auto |
| option | $0.39 | Nov 8, 2027 409d | 2.5M | OTM | 1.0% | C$975K | Auto |
| option | $0.35 | May 25, 2028 608d | 600K | OTM | 0.2% | C$210K | Auto |
| option | $0.48 | Jun 12, 2028 626d | 4.7M | OTM | 1.8% | C$2.3M | Auto |
| option | $0.19 | Feb 7, 2029 866d | 12.0M | OTM | 4.6% | C$2.3M | Auto |
| option | $0.16 | Apr 12, 2029 930d | 3.0M | OTM | 1.2% | C$480K | Auto |
| option | $0.14 | Sep 26, 2030 1462d | 400K | OTM | 0.2% | C$56K | Auto |
| option | $0.13 | Jan 8, 2031 1566d | 3.0M | OTM | 1.2% | C$390K | Auto |
An issuer that discloses only a plan total appears as one line at its weighted-average exercise price and weighted-average remaining life — the filing's own summary, not a per-grant schedule.
258,994,127 shares outstanding, plus 0 from warrants and 26,600,000 from options — a fully diluted 285,594,127 shares, or ~10.3% above today's count if every one of them is exercised.
Price history with the company's supply walls overlaid — warrants (amber), employee and consultant options (pink), and free-trading unlock dates (violet). Each wall sits at the price the paper is struck at today, restated through any consolidation, and is measured in the SHARES it can issue rather than the number of certificates. Levels and dates are Pacific Time.
